BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24504171)

  • 1. Allitridin reduces I Kr current by disrupting the trafficking of human ether-à-go-go-related gene channels.
    Li G; Cheng G; Wu J; Ma S; Zhang A; Han W; Sun C
    Cardiology; 2014; 128(1):1-8. PubMed ID: 24504171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EGFP/hERG fusion protein alter the electrophysiological properties of hERG channels in HEK293 cells.
    Huang N; Lian JF; Huo JH; Liu LY; Ni L; Yang X; Zhou JQ; Li ZF; Song TS; Huang C
    Cell Biol Int; 2011 Mar; 35(3):193-9. PubMed ID: 21143190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel missense mutation causing a G487R substitution in the S2-S3 loop of human ether-à-go-go-related gene channel.
    Kinoshita K; Yamaguchi Y; Nishide K; Kimoto K; Nonobe Y; Fujita A; Asano K; Tabata T; Mori H; Inoue H; Hata Y; Fukurotani K; Nishida N
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1246-53. PubMed ID: 22764740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
    Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
    Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the whole-cell patch-clamp configuration on the pharmacological assessment of the hERG channel: trazodone as a case example.
    Rodriguez-Menchaca AA; Ferrer T; Navarro-Polanco RA; Sanchez-Chapula JA; Moreno-Galindo EG
    J Pharmacol Toxicol Methods; 2014; 69(3):237-44. PubMed ID: 24412489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.
    Zeng H; Lozinskaya IM; Lin Z; Willette RN; Brooks DP; Xu X
    J Pharmacol Exp Ther; 2006 Nov; 319(2):957-62. PubMed ID: 16928897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel.
    Kang J; Chen XL; Wang H; Ji J; Cheng H; Incardona J; Reynolds W; Viviani F; Tabart M; Rampe D
    Mol Pharmacol; 2005 Mar; 67(3):827-36. PubMed ID: 15548764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of IKr and its trafficking disruption induced by probucol in cultured neonatal rat cardiomyocytes.
    Guo J; Massaeli H; Li W; Xu J; Luo T; Shaw J; Kirshenbaum LA; Zhang S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):911-20. PubMed ID: 17377062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HERG-F463L potassium channels linked to long QT syndrome reduce I(Kr) current by a trafficking-deficient mechanism.
    Yang HT; Sun CF; Cui CC; Xue XL; Zhang AF; Li HB; Wang DQ; Shu J
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):822-7. PubMed ID: 19215240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of HERG cardiac K+ current by antifungal drug miconazole.
    Kikuchi K; Nagatomo T; Abe H; Kawakami K; Duff HJ; Makielski JC; January CT; Nakashima Y
    Br J Pharmacol; 2005 Mar; 144(6):840-8. PubMed ID: 15778703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of a novel fluoroquinolone antibiotic agent antofloxacin hydrochloride on human-ether-à-go-go-related gene potassium channel.
    Guo J; Han SN; Liu JX; Zhang XM; Hu ZS; Shi J; Zhang LR; Zhao ZZ; Zhang Z
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):643-9. PubMed ID: 20662825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects and mechanism of dihydroberberine on hERG channels expressed in HEK293 cells.
    Yu D; Lv L; Fang L; Zhang B; Wang J; Zhan G; Zhao L; Zhao X; Li B
    PLoS One; 2017; 12(8):e0181823. PubMed ID: 28763460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the HERG channel by droperidol depends on channel gating and involves the S6 residue F656.
    Luo T; Luo A; Liu M; Liu X
    Anesth Analg; 2008 Apr; 106(4):1161-70, table of contents. PubMed ID: 18349188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginkgo biloba extract and ginkgolide antiarrhythmic potential by targeting hERG and ICa-L channel.
    Zhao X; Yao H; Yin HL; Zhu QL; Sun JL; Ma W; Shi YQ; Liang ZG; Li BX
    J Pharmacol Sci; 2013; 123(4):318-27. PubMed ID: 24225402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a novel anti-arrhythmic drug, acehytisine hydrochloride, on the human ether-a-go-go related gene K channel and its trafficking.
    Huang X; Yang Y; Zhu J; Dai Y; Pu J
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):145-54. PubMed ID: 19143746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gating of HERG potassium channels by cobalt and lanthanum.
    Sanchez-Chapula JA; Sanguinetti MC
    Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
    Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
    Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells.
    Du X; Lu D; Daharsh ED; Yao A; Dewoody R; Yao JA
    J Pharmacol Toxicol Methods; 2006; 54(2):164-72. PubMed ID: 16782359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.